Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down - Time to Sell?

Key Points

• Shares gapped down at the open to $10.62 from a prior close of $10.94 on light volume (~1,963 shares), and the stock carries a consensus Hold rating after a Goldman Sachs upgrade.
• Solid fundamentals: Shionogi beat Q1 estimates (EPS $0.28 vs $0.19; revenue $966.5M vs $848.4M), has very low debt (D/E 0.01), high liquidity (current ratio 5.84), a 41.8% net margin, and a P/E of 13.95 with a PEG of 0.87.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $10.94, but opened at $10.62. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $10.62, with a volume of 1,963 shares changing hands.

Analyst Ratings Changes

Separately, The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR to a "hold" rating in a report on Wednesday. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of "Hold".

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The company has a debt-to-equity ratio of 0.01, a current ratio of 5.84 and a quick ratio of 5.21. The stock has a market cap of $18.03 billion, a P/E ratio of 13.95, a P/E/G ratio of 0.87 and a beta of 0.19. The company's 50 day simple moving average is $11.05 and its 200 day simple moving average is $9.52.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last issued its earnings results on Friday, January 30th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.19 by $0.09. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.82% and a return on equity of 13.70%. The firm had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million. As a group, equities analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company's product portfolio spans both established and innovative therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.